- Summary
- Table Of Content
- Methodology
Home Infusion Therapy Market Size:
Home Infusion Therapy Market size is growing with a CAGR of 5.8% during the forecast period (2024-2031), and the market is projected to be valued at USD 54,775.49 Million by 2031 from USD 35,200.00 Million in 2023.
Home Infusion Therapy Market Scope & Overview:
Infusion therapy is a medical procedure that involves the administration of medications directly into a patient's bloodstream through a needle or catheter. Home infusion therapy is a treatment approach that involves administering medications to a patient at home through an intravenous or subcutaneous route. It involves administering antibiotics, chemotherapy drugs, enteral & parenteral nutrition, pain medications, and others. For specialized treatments, immune globulin, enzyme replacement therapies, bleeding disorder therapies, and heart failure medications are often infused.
Home infusion equipment and supplies include pumps, intravenous sets, catheters, needle-free connectors, and others. Home infusion therapy services encompass a range of activities, including patient assessment, medication preparation, equipment setup, monitoring, and others. The growing preference for home healthcare and technological advancements in infusion products are prominent factors supporting the market expansion.
Home Infusion Therapy MarketDynamics - (DRO) :
Key Drivers:
The Growing Preference for Home Healthcare is Fueling the Home Infusion Therapy Market Growth
Demographic shifts, such as the aging of individuals and the rising prevalence of chronic diseases, have increased the demand for home care services. The increasing prevalence of chronic diseases such as diabetes, cancer, and heart disease among others necessitate long-term treatments. Additionally, healthcare reform initiatives, including the shift to outpatient care and expanded insurance coverage, have made home care more accessible and affordable. Additionally, changing consumer preferences, with individuals seeking to maintain independence and improve quality of life, have contributed to the rising adoption of home healthcare.
- For instance, according to the data published by us Media, a company that provides data and insights on topics such as consumer behavior, market trends, and emerging technologies in April 2024, it is stated that about 12 million Americans receive home healthcare services each year. The majority of home healthcare patients in the U.S. are aged 65 and older, representing 86% of the total patient population. The most common medical conditions requiring home healthcare include cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, and Alzheimer’s disease.
Home infusion therapy provides a convenient and cost-effective way to deliver complex treatments to elderly patients, reducing the need for hospitalizations and improving quality of life. It enables patients to receive treatments in the comfort of their own homes, improving adherence and reducing the risk of complications. By reducing hospital stays and associated costs, such as room and board, it significantly lowers healthcare expenses. Moreover, home-based care prevents unnecessary hospitalizations and complications, further reducing costs. Ultimately, it provides a convenient and personalized approach to healthcare, empowering patients to take control of their treatment. As a result, as per analysis, the growing preference for home healthcare is driving the home infusion therapy market growth.
Technological Advancements in Home Infusion Therapy Products are Accelerating Market Expansion
Technological advancements have significantly improved the delivery and management of home infusion therapy, enhancing patient comfort and safety. Advancements such as the development of smart infusion pumps, implantable infusion devices, wearables, and advanced drug delivery systems help improve therapy outcomes. Smart infusion pumps feature wireless connectivity, allowing healthcare providers to remotely monitor and control therapy settings. Wearable injectors are single-use systems that are comfortably worn on the body while the drug is subcutaneously administered over a pre-programmed period.
Implantable drug delivery systems deliver an active drug to a target organ or body compartment for prolonged periods. The implantable pump implanted underneath the skin operates by battery and connects to a tube or catheter that is placed in the appropriate body area. Additionally, the advancements in catheters developed for infusion therapy are supporting the adoption of home infusion therapy.
- For instance, in October 2023, Braun, one of the key players in smart infusion therapy, unveiled its latest advancement, the Introcan Safety 2 IV Catheter with Multi-Access Blood Control. The multi-access blood control feature, capable of multiple activations, significantly reduces blood exposure and spillage during the IV process, enhancing safety for healthcare professionals. The multi-access blood control feature of this catheter works multiple times, helping to reduce blood exposure and spillage throughout the IV process.
These innovations enhance therapy outcomes by improving adherence, reducing side effects, and optimizing drug delivery, further fuelling the home infusion therapy market expansion.
Key Restraints :
Stringent Regulations for Home Infusion Therapy Products are Hampering the Market
The home infusion therapy products are subject to stringent regulations aimed at ensuring patient safety. The regulations present significant constraints for pharmaceutical and medical device companies. One major factor is the lengthy and complex development process for products such as drugs and medical devices. Clinical trials are rigorous and time-consuming, requiring substantial investment and resources. Navigating complex regulatory pathways, including submissions to regulatory agencies including the FDA (Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Pharmaceuticals and Medical Devices Agency) significantly hinder the timely introduction of new infusion products.
Furthermore, post-market survey and safety monitoring requirements add to the regulatory burden. Companies must continuously monitor the safety and efficacy of their products, which becomes costly and resource-intensive, especially for smaller players. The rigorous regulatory environment also hinders innovation within the industry, as companies are hesitant to invest in risky or unconventional approaches due to the high cost of failure. Overall, the regulations delay product approvals, increase costs, and limit profitability, especially for smaller companies further hampering the market.
Future Opportunities :
The Adoption of Software Solutions for Home Infusion Therapy is Expected to Create Opportunities for the Market
The development of software solutions specifically designed for home infusion therapy is the potential factor supporting the improvement in the infusion therapy provision. Infusion management software offers real-time insights and historical data analysis to optimize infusion pump utilization and gain valuable operational intelligence. By streamlining workflows, automating tasks, and improving communication, these solutions enhance efficiency and productivity. Real-time data access supports clinicians make informed decisions and respond promptly to patient needs.
Additionally, software solutions contribute to improved patient outcomes by reducing readmissions and enhancing patient satisfaction. Cost reduction is another significant benefit, as automation and optimized inventory management lead to significant savings. Owing to these advantages, companies are increasingly focusing on software solutions for home infusion therapy.
- For instance, in March 2024, Cencora, a global healthcare company, announced a strategic partnership with WeInfuse, an infusion software provider, to bolster its infusion strategies. As part of the partnership, Cencora provided funding to accelerate WeInfuse’s development of its home infusion software capabilities.
As a result, the integration of software solutions into home infusion therapy is expected to create potential home infusion therapy market opportunities in the upcoming years.
Home Infusion Therapy Market Segmental Analysis :
By Component:
Based on components, the market is bifurcated into products and services.
Trends in the Component:
- Increasing demand for wireless and wearable pumps.
- Adoption of antimicrobial coatings in intravenous sets to reduce infection risk.
- Advancements in biocompatible materials for catheters to minimize irritation.
The products segment accounted for the largest market share in 2023 and is also expected to grow at the fastest CAGR over the forecast period.
- The segment is further categorized into infusion pumps, intravenous sets, catheters, needle-free connectors, and others.
- Home infusion therapy leverages a range of specialized products to deliver medications directly into the bloodstream at home.
- An infusion pump is a medical device used to deliver fluids into a patient's body in a controlled manner.
- Catheters are essential components of home infusion therapy, providing a reliable way to deliver medications directly into the bloodstream.
- Intravenous sets and tubing connect the pump to the catheter, ensuring precise medication delivery. Additionally, needles, syringes, safety devices, dressings, cleaning solutions, and medication administration kits are essential for safe and efficient home infusion therapy.
- Technological advancements in home infusion therapy products such as smart pumps, wearable devices, and remote monitoring systems among others are expected to create opportunities for the segment in the upcoming years.
The services segment is expected to grow at the fastest CAGR over the forecast period.
- Home infusion therapy services encompass a range of activities, including patient assessment, medication preparation, equipment setup, and ongoing monitoring. These services are provided by trained healthcare professionals who ensure that patients receive the appropriate care in their homes.
- Home infusion therapy providers offer a variety of services, including infusion suite services. These services include comprehensive training and education on the care and maintenance of vascular access devices, covering hygiene practices, emergency procedures, infection prevention, and catheter care.
- Additionally, healthcare providers conduct thorough patient assessments, evaluate medical history, and identify potential complications. Regular monitoring, including remote monitoring, allows for timely communication with patients and physicians, ensuring adherence to therapy and addressing any concerns.
- Visiting nurses serve a crucial role, in training patients or caregivers in self-administration, educating them on side effects and treatment goals, and conducting periodic site assessments and dressing changes. These factors support the expansion of home infusion therapy services.
- For instance, in February 2024, Dynamic Access, LLC, a provider of vascular access solutions, announced the launch of a new affiliate brand, Dynamic Infusion, which will provide home infusion nursing services for patients with chronic conditions such as autoimmune disorders, hemophilia, Crohn's disease, rheumatoid arthritis, multiple sclerosis and more.
- Overall, home infusion therapy service is a holistic approach leading to improved health and well-being.
By Type:
Based on type, the market is categorized into anti-infective, hydration therapy, chemotherapy, pain management, nutrition, specialty therapies, and others.
Trends in the Type:
- Advancements in targeted therapies and personalized medicine.
- Advancements in parenteral nutrition formulations and delivery systems.
The anti-infective segment accounted for the largest market share of 32.15% in the year 2023.
- Anti-infective therapy involves the administration of antibiotics, antifungals, and antivirals to treat various infections.
- This therapy is particularly beneficial for patients with chronic infections, immunocompromised individuals, or those who require long-term antibiotic therapy.
- Home infusion therapy for anti-infective treatments offers several advantages, including reduced hospital stays, enhanced patient comfort, and improved adherence to treatment regimens.
- Higher incidences of infections along with the demand for reducing the risk of hospital-acquired infections is driving the adoption of home anti-infective infusion therapy.
- For instance, according to the data published by the World Health Organization in January 2023, it is stated that an estimated 10.6 million people contracted tuberculosis globally in 2021. Geographically, the highest prevalence of TB cases in 2021 was observed in the Southeast Asia region, accounting for 45% of global cases. The African region followed with 23% of cases, and the Western Pacific region contributed 18%. These incidences of tuberculosis create the requirements for effective treatment approaches including home infusion therapy.
- Overall, as per the analysis, the increasing prevalence of infectious diseases highlights the growing demand for home anti-infective infusion therapy. This drives the segment share in the overall home infusion therapy market trend.
The specialty therapies segment is expected to grow at the fastest CAGR over the forecast period.
- Specialty therapies include treatments for complex diseases such as cancer, autoimmune disorders, and rare diseases among others. These therapies often require specialized medications and precise dosing, making home infusion a suitable delivery method.
- Specialty therapies encompass a wide range of treatments, including monoclonal antibodies, biological therapies, immune globulin, enzyme replacement therapies, bleeding disorder therapies, heart failure therapy, and other specialized medications.
- The growing prevalence of chronic disorders, rising complexity of treatments, emphasis on patient-centric care, technological advancements, and the shift towards value-based care driving the segment in the overall home infusion therapy market trend.
- Thus, as per analysis, as the requirements for complex and personalized treatments continue to rise, the specialty therapies segment is poised to remain a significant contributor to the overall home infusion therapy market size and is expected to create home infusion therapy market opportunities in the forecast years.
Regional Analysis:
The regional segment includes North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
In 2023, North America accounted for the highest market share at 38.55% and was valued at USD 13,569.60 Million and is expected to reach USD 21,148.82 Million in 2031. In North America, the U.S. accounted for the highest market share of 73.45% during the base year of 2023. The home infusion therapy market expansion is gaining significant rise in North America owing to the confluence of multiple factors such as the growing prevalence of chronic disorders with cancer, diabetes, and autoimmune disorders, increasing the requirements for home infusion therapy. Additionally, North America boasts a well-developed healthcare infrastructure, including advanced medical facilities and skilled healthcare professionals that support the delivery of complex home infusion therapies. Moreover, the region's favorable reimbursement policies and government initiatives such as Medicare and Medicaid provide financial support for facilitating the adoption of home infusion therapy.
- For instance, based on the analysis published by the S. Centers for Medicare & Medicaid Services in September 2024, Medicare spending grew 5.9% to USD 944.3 billion in 2022, or 21% of total national healthcare (NHE) spending in the U.S. Medicaid spending grew 9.6% to USD 805.7 billion in 2022, or 18% of total NHE. Medicare provides health coverage for senior citizens, while Medicaid covers health care costs for people with low incomes.
Furthermore, the presence of major pharmaceutical and medical device companies in the region drives innovation and product development for infusion therapies. The combination of the aforementioned factors and trends is driving substantial growth in the North American home infusion therapy market share.
The Asia-Pacific is experiencing the fastest growth with a CAGR of 6.4% over the forecast period. The surge of home infusion therapy market analysis in the region is attributed to factors such as increasing disposable incomes and government initiatives that improve healthcare access leading to higher healthcare spending. Additionally, the aging population in countries like China, India, and Japan is increasing the requirements for home-based care, making home infusion therapy a convenient and effective solution. Moreover, the rising prevalence of chronic diseases such as diabetes and cancer necessitates long-term therapies, further boosting demand. Further, government support in the form of policies promoting healthcare accessibility and affordability is creating a favorable environment for the surge of home infusion therapy market demand in the region. Moreover, growing healthcare investments and expanding access to pharmaceuticals in the region are further fueling the market.
Europe holds a significant home infusion therapy market share. Driven by an aging population, increasing prevalence of chronic diseases, and favorable regulatory environments, this market is experiencing substantial growth across Europe. Countries like Germany, the UK, and France are key contributors to this growth, with a strong focus on patient-centric care and cost-effective solutions. Technology trends, such as smart infusion pumps and remote monitoring systems, are further enhancing the delivery of home infusion therapy across the region. Additionally, increased healthcare spending is enabling investments in advanced home infusion technologies and services. As healthcare systems prioritize home-based care, the European market is expected to continue its grow, offering innovative solutions and improving patient outcomes.
As per the home infusion therapy market analysis, the Middle East and Africa (MEA) region is witnessing notable trends in requirements for infusion therapy solutions provided in-home care. Factors such as increasing healthcare expenditure in countries like Saudi Arabia and the United Arab Emirates are driving the adoption of advanced medical technologies, including home infusion therapy. Additionally, a growing awareness of the benefits of home-based care, including improved patient comfort, reduced hospital stays, and enhanced adherence to treatment plans, is leading to a gradual shift towards home infusion therapy. Moreover, with increasing government support and investments in healthcare infrastructure, the Middle East and Africa region is expected to witness significant growth trends in the coming years.
As per market analysis, Latin America's home infusion therapy market demand is experiencing steady growth due to several factors. Rising awareness about the benefits of home-based care, including improved patient comfort and reduced healthcare costs, is driving requirements for home infusion services. The growing middle class with increased disposable income is fueling demand for quality healthcare services, including specialized therapies that require home infusion. Furthermore, government initiatives aimed at improving healthcare access and affordability are supporting the adoption of home infusion therapy in the region. As these trends continue, the Latin American market is poised for significant growth in the coming years.
Top Key Players & Market Share Insights:
The home infusion therapy market is highly competitive with major players providing services to the national and international markets. Key players are adopting several strategies in service provision to hold a strong position in the global home infusion therapy market. Key players in the home infusion therapy industry include-
- Portea Medical (India)
- Option Care Health Inc. (U.S.)
- Baxter (U.S.)
- BD (U.S.)
- Medtronic (Ireland)
- Fresenius Kabi (Germany)
- CarePro Health Services (U.S.)
- Dynamic Access (U.S.)
- Cottrill's Pharmacy (U.S.)
- Geisinger Health (U.S.)
- Braun SE (Germany)
- Terumo Corporation (Japan)
Recent Industry Developments :
Launches:
- In November 2024, TriSalus Life Sciences Inc., a leader in oncology innovations, announced the launch of the TriNav LV Infusion System and TriGuide Guiding Catheter. These new devices are designed to optimize therapeutic delivery, enhancing treatment options and potentially improving outcomes for patients.
- In October 2024, Geisinger Pharmacy, a provider of value-based care, launched a new infusion suite at Wilkes-Barre that offers patients a personalized approach to their specialized pharmacy and medication needs.
- In April 2024, Baxter International Inc., a key player in infusion therapies and technologies, announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software.
- In April 2022, AmerisourceBergen (AB), a global healthcare company, announced the launch of a program designed to help hospitals and health systems launch or optimize home infusion service lines. AB’s solution is designed to help health systems deploy and operate a clinically focused home infusion program for patients who choose to receive care within a health system network.
Expansion:
- In February 2024, Dynamic Access, a renowned provider of vascular access solutions, expanded its services by launching Dynamic Infusion. This new affiliate brand will offer specialized home infusion nursing care for patients with chronic conditions such as autoimmune disorders, hemophilia, Crohn's disease, rheumatoid arthritis, multiple sclerosis, and others.
Partnership:
- In March 2024, Cencora, a global healthcare company, partnered with WeInfuse, an infusion software provider, to strengthen its infusion services. Cencora has invested in WeInfuse to accelerate the development of advanced software solutions for home infusion and specialty pharmacy.
Home Infusion Therapy Market Report Insights :
| Report Attributes | Report Details |
| Study Timeline | 2018-2031 |
| Market Size in 2031 | USD 54,775.49 Million |
| CAGR (2024-2031) | 5.8% |
| By Component |
|
| By Type |
|
| By Region |
|
| Key Players |
|
| North America | U.S. Canada Mexico |
| Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
| APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
| Middle East and Africa | GCC Turkey South Africa Rest of MEA |
| LATAM | Brazil Argentina Chile Rest of LATAM |
| Report Coverage |
|
Key Questions Answered in the Report
How big is the Home Infusion Therapy market? +
In 2023, the Home Infusion Therapy market is USD 35,200.00 Million.
Which is the fastest-growing region in the Home Infusion Therapy market? +
Asia Pacific is the fastest-growing region in the Home Infusion Therapy market.
What specific segmentation details are covered in the Home Infusion Therapy market? +
Component and Type segmentation details are covered in the Home Infusion Therapy market
Who are the major players in the Home Infusion Therapy market? +
Portea Medical (India), Option Care Health Inc. (U.S.), and CarePro Health Services (U.S.) are some of the major players in the market.
